← Human Trials & Peer-Reviewed Studies
Hpa II polymorphism of the atrial natriuretic peptide gene and the blood pressure response to salt intake in normotensive men
Plain-language guide to PMID 9222938 (1997): double-blind randomized controlled trial study of ANP (Atrial Natriuretic Peptide), low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 9222938
- Journal
- Journal of hypertension
- Year
- 1997
- Study type
- Randomized Controlled Trial
- Authors
- Schorr U et al. (7 authors)
- DOI
- 10.1097/00004872-199715070-00002
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of ANP (Atrial Natriuretic Peptide) in the context of low blood pressure and orthostatic hypotension, published as a randomized controlled trial.
To test the hypothesis that the Hpa II variant of the atrial natriuretic peptide gene (ANP), which has been reported to be more common among black hypertensives than it is among normotensive controls, is related to the response of blood pressure to salt intake in normotensive Caucasians.
Who Took Part
The age groups tagged for this paper are adults, men only.
How the Study Was Run
The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.
Because people in this ANP (Atrial Natriuretic Peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
Blinding on both sides kept the participants and researchers unaware of who received ANP (Atrial Natriuretic Peptide).
The comparison arm used a placebo, so changes seen with ANP (Atrial Natriuretic Peptide) could be set against what happens without it.
In the crossover set-up each of the participants took both ANP (Atrial Natriuretic Peptide) and the comparison in turn, acting as their own control.
The genotype was determined by amplification of genomic DNA extracted from peripheral leukocytes and subsequent digestion of the amplicon with Hpa II restriction enzyme.
What Was Measured
The subject headings attached to it are Alleles, Atrial Natriuretic Factor, Base Sequence, Blood Pressure, DNA Primers, Deoxyribonuclease HpaII and Diet, Sodium-Restricted.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of ANP (Atrial Natriuretic Peptide) in people with low blood pressure and orthostatic hypotension.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 1997 (Journal of hypertension), a journal based in Netherlands.
More context: the ANP (Atrial Natriuretic Peptide) compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
ANP (Atrial Natriuretic Peptide): A 28-amino-acid heart hormone that relaxes blood vessels and increases salt excretion; carperitide is a recombinant form.
Related Pages
- Low blood pressure and orthostatic hypotension research
- ANP (Atrial Natriuretic Peptide) in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.